Ignite Creation Date:
2024-05-06 @ 2:38 PM
Last Modification Date:
2024-10-26 @ 1:35 PM
Study NCT ID:
NCT04388384
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-10-24
First Post:
2020-05-05
Brief Title:
Real-life Pan-HER-blockade With Neratinib
Sponsor:
Pierre Fabre Pharma GmbH
Organization:
Pierre Fabre Pharma GmbH
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-02
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-05
First Submit QC Date:
May 13 2020
Study First Post Date:
2020-05-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-23
Last Update Post Date:
2023-10-24
Last Update Post Date Type:
ACTUAL